Suffer from Allergies? Compensated Clinical Study Seeking Panelists

Acurian is looking for panelists in certain states/zip codes to join an allergy study. Here’s some info:

We’re currently helping a pharmaceutical company find people 5 to 65 years of age who suffer from seasonal allergies that are willing to participate in a clinical research study in your area (Only Certain Zipcodes Qualify). Research study needs volunteers with seasonal allergies.

I work with Acurian, a company that connects people with clinical research doctors. We’re currently helping a pharmaceutical company find people 5 to 65 years of age who suffer from seasonal allergies that are willing to participate in a clinical research study in your area. Seasonal allergies may result in additional health problems, including asthma. Research doctors are enrolling today and health insurance is not required.

All information is kept strictly confidential. If you or your child is burdened with seasonal allergies, call us to learn more about the benefits and risks of the study or click here. Qualified participants may receive at no-cost:

• Study-related doctor visits and examinations up to 15 months

• Investigational oral medication

• Allergy medications during the 2012 pollen season

• Compensation for time and travel

Visit today

NOTE only Certain Zipcodes will qualify
The qualifying Zipcodes are found in the following states:
New York, Pennsylvania, Maryland, Massachusetts, Ohio, Michigan, Missouri, Colorado, Idaho, Utah, California, Oregon, Washington, Rhode Island, Connecticut, New Jersey

I would not join a clinical trial myself, but I know some people have no issues with it and since this is a compensated opportunity, I figured it was worth bringing to the FFF reader’s attention.

I checked out the company Acurian and this is what I found:

Acurian is a leading full-service provider of clinical trial patient recruitment and retention solutions for the life sciences industry. Through its proprietary patient panel of over 65 million patients, centralized advertising capabilities, and a fully hosted enrollment management technology platform, Acurian is able to identify, contact, prescreen, and refer patients into clinical trials, all while supporting investigator sites with services to maximize the randomization potential of every referred patient. Since 1998, Acurian has supported over 400 protocols for more than 60 companies. Acurian’s investors include Euclid SR Partners, ProQuest Investments, JP Morgan Partners, Flatiron Partners, CDP Capital Technology Ventures, and Merck Capital Ventures.

Source: Here

If you are interested in signing up, click here and fill out the questionairre to see if you qualify.

Enjoy!